Identification of Hub Genes Related to Metastasis and Prognosis of Osteosarcoma and Establishment of a Prognostic Model with Bioinformatic Methods

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Jun 7

PMID 38847690

Authors

Zheng Fu

Guofeng Sun

Jingtian Li

Hongjian Yu

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor occurring in children and adolescents. Improvements in our understanding of the OS pathogenesis and metastatic mechanism on the molecular level might lead to notable advances in the treatment and prognosis of OS. Biomarkers related to OS metastasis and prognosis were analyzed and identified, and a prognostic model was established through the integration of bioinformatics tools and datasets in multiple databases. 2 OS datasets were downloaded from the Gene Expression Omnibus database for data consolidation, standardization, batch effect correction, and identification of differentially expressed genes (DEGs); following that, gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on the DEGs; the STRING database was subsequently used for protein-protein interaction (PPI) network construction and identification of hub genes; hub gene expression was validated, and survival analysis was conducted through the employment of the TARGET database; finally, a prognostic model was established and evaluated subsequent to the screening of survival-related genes. A total of 701 DEGs were identified; by gene ontology and KEGG pathway enrichment analyses, the overlapping DEGs were enriched for 249 biological process terms, 13 cellular component terms, 35 molecular function terms, and 4 KEGG pathways; 13 hub genes were selected from the PPI network; 6 survival-related genes were identified by the survival analysis; the prognostic model suggested that 4 genes were strongly associated with the prognosis of OS. DEGs related to OS metastasis and survival were identified through bioinformatics analysis, and hub genes were further selected to establish an ideal prognostic model for OS patients. On this basis, 4 protective genes including TPM1, TPM2, TPM3, and TPM4 were yielded by the prognostic model.

Citing Articles

Advances in Soft Tissue and Bone Sarcoma.

Rutland C Cancers (Basel). 2024; 16(16).

PMID: 39199646 PMC: 11352553. DOI: 10.3390/cancers16162875.

References

Anggorowati N, Ratna Kurniasari C, Damayanti K, Cahyanti T, Widodo I, Ghozali A . Histochemical and Immunohistochemical Study of α-SMA, Collagen, and PCNA in Epithelial Ovarian Neoplasm. Asian Pac J Cancer Prev. 2017; 18(3):667-671. PMC: 5464482. DOI: 10.22034/APJCP.2017.18.3.667. View

Wu G, Guo Z, Chang X, Kim M, Nagpal J, Liu J . LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 2007; 67(9):4123-9. DOI: 10.1158/0008-5472.CAN-07-0012. View

Lee H, Park Y, Lee S, Cho H, Kim D, Lee J . Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res. 2013; 19(21):5879-89. DOI: 10.1158/1078-0432.CCR-13-1181. View

Molyneux S, Di Grappa M, Beristain A, McKee T, Wai D, Paderova J . Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest. 2010; 120(9):3310-25. PMC: 2929719. DOI: 10.1172/JCI42391. View

Morrow J, Mendoza A, Koyen A, Lizardo M, Ren L, Waybright T . mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo. Clin Cancer Res. 2016; 22(24):6129-6141. PMC: 5161706. DOI: 10.1158/1078-0432.CCR-16-0326. View

Massard C, Michiels S, Ferte C, Le Deley M, Lacroix L, Hollebecque A . High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial. Cancer Discov. 2017; 7(6):586-595. DOI: 10.1158/2159-8290.CD-16-1396. View

Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, Toscano A . Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther. 2011; 11(2):217-27. DOI: 10.1586/era.10.172. View

Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R . Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 2012; 21(4):491-9. DOI: 10.1007/s12282-012-0404-8. View

Yang W, Wang X, Zheng W, Li K, Liu H, Sun Y . Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma. Int J Oncol. 2012; 42(2):690-8. DOI: 10.3892/ijo.2012.1741. View

10.

Hitchcock-DeGregori S, Barua B . Tropomyosin Structure, Function, and Interactions: A Dynamic Regulator. Subcell Biochem. 2017; 82:253-284. DOI: 10.1007/978-3-319-49674-0_9. View

11.

Braun E, Hotter D, Koepke L, Zech F, Gross R, Sparrer K . Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. Cell Rep. 2019; 27(7):2092-2104.e10. DOI: 10.1016/j.celrep.2019.04.063. View

12.

Yang X, Wei W, Tan S, Guo L, Qiao S, Yao B . Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer. World J Surg Oncol. 2021; 19(1):248. PMC: 8380340. DOI: 10.1186/s12957-021-02335-x. View

13.

Yu S, Yu X, Sun L, Zheng Y, Chen L, Xu H . GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway. Oncogene. 2020; 39(27):5042-5055. DOI: 10.1038/s41388-020-1348-7. View

14.

Zhao W, Yang A, Chen W, Wang P, Liu T, Cong M . Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(4 Pt A):1129-1137. DOI: 10.1016/j.bbadis.2018.01.019. View

15.

Flores R, Li Y, Yu A, Shen J, Rao P, Lau S . A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol. 2012; 6:50. PMC: 3431263. DOI: 10.1186/1752-0509-6-50. View

16.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

17.

Lees J, Bach C, ONeill G . Interior decoration: tropomyosin in actin dynamics and cell migration. Cell Adh Migr. 2010; 5(2):181-6. PMC: 3084984. DOI: 10.4161/cam.5.2.14438. View

18.

Zhi K, Shen X, Zhang H, Bi J . Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers. J Exp Clin Cancer Res. 2010; 29:66. PMC: 2892440. DOI: 10.1186/1756-9966-29-66. View

19.

Chen Y, Di Grappa M, Molyneux S, McKee T, Waterhouse P, Penninger J . RANKL blockade prevents and treats aggressive osteosarcomas. Sci Transl Med. 2015; 7(317):317ra197. DOI: 10.1126/scitranslmed.aad0295. View

20.

Ritter J, Bielack S . Osteosarcoma. Ann Oncol. 2010; 21 Suppl 7:vii320-5. DOI: 10.1093/annonc/mdq276. View